209 related articles for article (PubMed ID: 19055172)
1. The effect of vehicle formulation on acne medication tolerability.
Draelos ZD; Callender V; Young C; Dhawan SS
Cutis; 2008 Oct; 82(4):281-4. PubMed ID: 19055172
[TBL] [Abstract][Full Text] [Related]
2. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
Draelos ZD; Potts A; Alió Saenz AB;
Cutis; 2010 Dec; 86(6):310-8. PubMed ID: 21284283
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, randomized, bilateral comparison of skin irritancy following application of the combination acne products clindamycin/tretinoin and benzoyl peroxide/adapalene.
Goreshi R; Samrao A; Ehst BD
J Drugs Dermatol; 2012 Dec; 11(12):1422-6. PubMed ID: 23377511
[TBL] [Abstract][Full Text] [Related]
4. The development and optimization of a fixed combination of clindamycin and benzoyl peroxide aqueous gel.
Bucks D; Sarpotdar P; Yu K; Angel A; Del Rosso J
J Drugs Dermatol; 2009 Jul; 8(7):634-8. PubMed ID: 19588639
[TBL] [Abstract][Full Text] [Related]
5. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
Gonzalez P; Vila R; Cirigliano M
J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris.
Dhawan SS
Cutis; 2009 May; 83(5):265-72. PubMed ID: 19537284
[TBL] [Abstract][Full Text] [Related]
7. Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
Cook-Bolden FE
J Drugs Dermatol; 2012 Apr; 11(4):455-9. PubMed ID: 22453581
[TBL] [Abstract][Full Text] [Related]
8. Topical Vehicle Formulations in the Treatment of Acne.
Hoffman LK; Bhatia N; Zeichner J; Kircik LH
J Drugs Dermatol; 2018 Jun; 17(6):s6-s10. PubMed ID: 29879262
[TBL] [Abstract][Full Text] [Related]
9. How patients experience and manage dryness and irritation from acne treatment.
Feldman SR; Chen DM
J Drugs Dermatol; 2011 Jun; 10(6):605-8. PubMed ID: 21637901
[TBL] [Abstract][Full Text] [Related]
10. Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne.
Callender VD
J Drugs Dermatol; 2012 May; 11(5):643-8. PubMed ID: 22527435
[TBL] [Abstract][Full Text] [Related]
11. Cumulative irritancy comparison of topical retinoid and antimicrobial combination therapies.
Dosik JS; Gilbert RD; Arsonnaud S
Skinmed; 2006; 5(5):219-23. PubMed ID: 16957432
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of the addition of salicylic acid to clindamycin and benzoyl peroxide combination for acne vulgaris.
Akarsu S; Fetil E; Yücel F; Gül E; Güneş AT
J Dermatol; 2012 May; 39(5):433-8. PubMed ID: 22035285
[TBL] [Abstract][Full Text] [Related]
13. A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide.
Thiboutot D; Eichenfield L; Shalita A; Del Rosso JQ; Swinyer L; Tanghetti E; Tschen E; Parr L
Cutis; 2009 Jul; 84(1):48-55. PubMed ID: 19743725
[TBL] [Abstract][Full Text] [Related]
14. Combination topical therapy in the treatment of acne.
Del Rosso JQ
Cutis; 2006 Aug; 78(2 Suppl 1):5-12. PubMed ID: 17966494
[TBL] [Abstract][Full Text] [Related]
15. Fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel: a flexible component of acne management.
Tanghetti E
Cutis; 2009 Nov; 84(5 Suppl):18-24. PubMed ID: 19999189
[TBL] [Abstract][Full Text] [Related]
16. Clindamycin phosphate 1·2%-benzoyl peroxide 3·0% fixed-dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single-blinded, active-controlled, parallel-group study.
Kawashima M; Hashimoto H; Alió Sáenz AB; Ono M; Yamada M
Br J Dermatol; 2015 Feb; 172(2):494-503. PubMed ID: 25040180
[TBL] [Abstract][Full Text] [Related]
17. Benzoyl peroxide microsphere cream as monotherapy and combination treatment of acne.
Bikowski J; Del Rosso JQ
J Drugs Dermatol; 2008 Jun; 7(6):590-5. PubMed ID: 18561594
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
Eichenfield LF; Alió Sáenz AB
J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
[TBL] [Abstract][Full Text] [Related]
19. Advances in topical delivery systems in acne: new solutions to address concentration dependent irritation and dryness.
Ceilley RI
Skinmed; 2011; 9(1):15-21. PubMed ID: 21409958
[TBL] [Abstract][Full Text] [Related]
20. A multicenter, double-blind study to evaluate the efficacy and safety of 2 treatments in participants with mild to moderate acne vulgaris.
Draelos ZD; Shalita AR; Thiboutot D; Oresajo C; Yatskayer M; Raab S
Cutis; 2012 Jun; 89(6):287-93. PubMed ID: 22838094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
